Project 170729

The Role of Tim-3 in T Cell Exhaustion in HIV-1 Infection

170729

The Role of Tim-3 in T Cell Exhaustion in HIV-1 Infection

$328,650
Project Information
Study Type: Other Mechanistic_Study
Therapeutic Area: Infectious_Disease
Research Theme: Biomedical
Disease Area: HIV/AIDS
Data Type: Canadian
Institution & Funding
Principal Investigator(s): Ostrowski, Mario A
Institution: University of Toronto
CIHR Institute: Infection and Immunity
Program: Operating Grant
Peer Review Committee: Virology & Viral Pathogenesis
Competition Year: 2008
Term: 3 yrs 0 mth
Abstract Summary

One of the greatest mysteries of Human Immunodeficiency Virus Type 1 (HIV-1) infection has been to understand why the normal immune system is unable to eradicate or control this virus infection as opposed to other virus infections. Our laboratory specializes in understanding how one arm of the immune system, called the T cells, fights viruses, including HIV-1 virus, the virus that causes AIDS (acquired immunodeficiency syndrome). It has been found that these T cells that are supposed to fight HIV-1 do a bad job, and have been called dysfunctional, or exhausted. Recently a clue to why these T cells are exhausted was demonstrated by numerous publications that have identified a new molecule on the surface of these exhausted cells called PD-1. We have now identified, another new molecule on the surface of these exhausted T cells called Tim-3 (T cell immunoglobulin mucin molecule type 3). We have found that Tim-3 identifies the most exhausted of these T cells. We also show that by blocking the action of this Tim-3 molecule on the T cell, we can rescue the function of these cells to fight HIV better. The current project will try to understand why Tim-3 is increased in HIV infection in order to develop new therapies to block the actions of Tim-3 so that infected persons can fight the virus better and possibly get rid of it, as well as develop new ways of vaccinating against the virus in uninfected persons.

Research Characteristics

This project includes the following research characteristics:

Regulatory Pathway
Knowledge Translation Focus
Biomarker Endpoints
Vulnerable Populations
Personalized Medicine
Study Justification

"try to understand why Tim-3 is increased in HIV infection in order to develop new therapies to block the actions of Tim-3 so that infected persons can fight the virus better"

Novelty Statement

"We have now identified, another new molecule on the surface of these exhausted T cells called Tim-3 (T cell immunoglobulin mucin molecule type 3)."

Methodology Innovation

investigating Tim-3 as a novel therapeutic target to reverse T cell exhaustion in HIV-1 infection

Keywords
Anergy Chronic Virus Infection Exhaustion Hiv T Cells Tim-3